Articles

News

Study shows action of molecules on the new coronavirus

Several patients infected with the new coronavirus (SARS-CoV-2) show an exacerbated inflammatory response caused by an exagerated activity of the patient’s immune system, in the attempt to protect the body from the pathogen.

03/09/2020 Lucas Rocha (IOC/Fiocruz) Several patients infected with the new coronavirus (SARS-CoV-2) show an exacerbated inflammatory response caused by an exagerated activity of the patient’s immune system, in the attempt to protect the body from the pathogen. This activity is ... Read more

Covid-19 cases may take up to seven weeks to be made public

This discrepancy can make a big difference, for instance, in the stages of social isolation flexibilization.

25/08/2020 Icict/Fiocruz The new coronavirus pandemic has been posing unheard-of challenges to health information systems. Covid-19 data in Brazil, both at a state and municipal level, are crucial for the decision making on public policies and emergency measures to contain ... Read more

Study boosts the performance of rapid test for Chagas disease

A research has analyzed the performance of chimeric antigens for the diagnosis of chronic Chagas disease using rapid tests.

11/09/2020 Fiocruz Bahia A research has analyzed the performance of chimeric antigens for the diagnosis of chronic Chagas disease using rapid tests. The study led by researcher Fred Luciano Neves Santos, of Fiocruz Bahia, used serum samples from different geographical ... Read more

Saiba mais sobre a parceria Fiocruz+Universidade de Oxford para a produção de uma vacina contra a COVID-19

Fiocruz is designated as reference institution in Covid-19 in the Americas for the WHO

The Laboratory for Respiratory Viruses and Measles has been formally acknowledged as reference in the continent, together with the CDC

Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more

Return to school is a risk for more than 9.3 million adults in Brazil

The number was calculated through a Fiocruz analysis, along with other partners, based on the National Health Survey (PNS 2013),

27/07/2020 Icict/Fiocruz Going back to school may represent an extra risk for more than 9.3 million Brazilians (4.4% of the overall population) who are elderly or adults (18 years and up) with chronic health conditions and at risk for Covid-19 ... Read more

Understanding the gendered dimensions of - COVID-19 - #InFocus

Watch the webinar in English 

  

Covid-19: Fiocruz will begin pre-clinical trials for a vaccine

The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2).

12/06/2020 Fiocruz The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be ... Read more

Fiocruz develops a protocol to sequence the new coronavirus

Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2.

02/06/2020 Maíra Menezes (IOC/Fiocruz) Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2. The methodology ... Read more

Fiocruz researcher Gustavo Matta says "COVID deaths are not numbers"

WATCH (In portuguese)

  

E-Learning